SELENBP1 and neoplasm: Taken together, our results provide clinical and molecular evidence for an improved understanding of the tumor-suppressive role of SELENBP1 in bladder cancer, suggesting that SELENBP1 could potentially be used as a prognostic biomarker as well as a therapeutic target in future cancer therapy.